4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 10, 2012, Pages 1544-1552

  Riedel, Travis J ^a   Knight, John ^a   Murray, Michael S ^a,c   Milliner, Dawn S ^b   Holmes, Ross P ^a   Lowther, W Todd ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c RIGAKU CORPORATION   (Japan)

Author keywords

Calcium oxalate stone disease; Hydroxyproline; Oxalate

Indexed keywords

4 HYDROXY 2 OXOGLUTARATE ALDOLASE; CELL ENZYME; GLUTARIC ACID DERIVATIVE; GLYOXYLATE REDUCTASE; N ACETYLNEURAMINATE ALDOLASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHO CELL; ENZYME INHIBITION; ESCHERICHIA COLI; FEMALE; GENETIC VARIABILITY; HUMAN; NONHUMAN; PRIMARY HYPEROXALURIA TYPE 3; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY;

ALCOHOL OXIDOREDUCTASES; ANIMALS; CELLS, CULTURED; CHO CELLS; CRICETINAE; GLUTARATES; HUMANS; HYDROXYPROLINE; HYPEROXALURIA, PRIMARY; KETOGLUTARIC ACIDS; LIVER; MITOCHONDRIA; MUTATION; OXALATES; OXO-ACID-LYASES; RECOMBINANT PROTEINS; TRANSFECTION;

CRICETULUS GRISEUS; ESCHERICHIA COLI;

EID: 84864234719     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.06.014     Document Type: Article

References (29)

1. Holmes R.P., Assimos D.G. Glyoxylate synthesis, and its modulation and influence on oxalate synthesis. J. Urol. 1998, 160:1617-1624.
2. Hoppe B., Beck B.B., Milliner D.S. The primary hyperoxalurias. Kidney Int. 2009, 75:1264-1271.
3. Knight J., Jiang J., Assimos D.G., Holmes R.P. Hydroxyproline ingestion and urinary oxalate and glycolate excretion. Kidney Int. 2006, 70:1929-1934.
4. Belostotsky R., Seboun E., Idelson G.H., Milliner D.S., Becker-Cohen R., Rinat C., Monico C.G., Feinstein S., Ben-Shalom E., Magen D., Weissman I., Charon C., Frishberg Y. Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am. J. Hum. Genet. 2010, 87:392-399.
5. Monico C.G., Rossetti S., Belostotsky R., Cogal A.G., Herges R.M., Seide B.M., Olson J.B., Bergstrahl E.J., Williams H.J., Haley W.E., Frishberg Y., Milliner D.S. Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. Clin. J. Am. Soc. Nephrol. 2011, 6:2289-2295.
6. Williams E.L., Bockenhauer D., Van't Hoff W.G., Johri N., Laing C., Sinha M.D., Unwin R., Viljoen A., Rumsby G. The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3. Nephrol. Dial. Transplant. 2012, 10.1093/ndt/gfs039.
7. Adams E., Frank L. Metabolism of proline and the hydroxyprolines. Annu. Rev. Biochem. 1980, 49:1005-1061.
8. Phang J.M., Hu C.A., Valle D. Disorders in proline and hydroxyproline metabolism. The metabolic and molecular bases of inherited disease 2001, 1821-1838. 8th ed.
9. Valle D., Goodman S.I., Harris S.C., Phang J.M. Genetic evidence for a common enzyme catalyzing the second step in the degradation of proline and hydroxyproline. J. Clin. Invest. 1979, 64:1365-1370.
10. Riedel T.J., Johnson L.C., Knight J., Hantgan R.R., Holmes R.P., Lowther W.T. Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria. PLoS One 2011, 6:e26021.
11. Danpure C.J. Molecular etiology of primary hyperoxaluria type 1: new directions for treatment. Am. J. Nephrol. 2005, 25:303-310.
12. Joerger A.C., Mayer S., Fersht A.R. Mimicking natural evolution in vitro: an N-acetylneuraminate lyase mutant with an increased dihydrodipicolinate synthase activity. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5694-5699.
13. Evans G., Schuldt L., Griffin M.D., Devenish S.R., Grant Pearce F., Perugini M.A., Dobson R.C., Jameson G.B., Weiss M.S., Gerrard J.A. A tetrameric structure is not essential for activity in dihydrodipicolinate synthase (DHDPS) from Mycobacterium tuberculosis. Arch. Biochem. Biophys. 2011, 512:154-159.
14. Kefala G., Evans G.L., Griffin M.D., Devenish S.R., Pearce F.G., Perugini M.A., Gerrard J.A., Weiss M.S., Dobson R.C. Crystal structure and kinetic study of dihydrodipicolinate synthase from Mycobacterium tuberculosis. Biochem. J. 2008, 411:351-360.
15. Muscroft-Taylor A.C., Catchpole R.J., Dobson R.C., Pearce F.G., Perugini M.A., Gerrard J.A. Disruption of quaternary structure in Escherichia coli dihydrodipicolinate synthase (DHDPS) generates a functional monomer that is no longer inhibited by lysine. Arch. Biochem. Biophys. 2010, 503:202-206.
16. Riggs P.D. In expression and purification of maltose-binding protein fusions. Current Protocols in Molecular Biology 1990, vol. 90:459-463. Academic Press, New York.
17. Williams G.J., Woodhall T., Nelson A., Berry A. Structure-guided saturation mutagenesis of N-acetylneuraminic acid lyase for the synthesis of sialic acid mimetics. Protein Eng. Des. Sel. 2005, 18:239-246.
18. Mdluli K., Booth M.P., Brady R.L., Rumsby G. A preliminary account of the properties of recombinant human glyoxylate reductase (GRHPR), LDHA and LDHB with glyoxylate, and their potential roles in its metabolism. Biochim. Biophys. Acta 2005, 1753:209-216.
19. Segel I.H. Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-state Enzyme Systems 1975, 178-192. Wiley-Interscience, New York.
20. 5-hydroxyproline in vitro and in vivo: implications for primary hyperoxaluria. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 302:G637-G643.
21. Coulter-Mackie M.B. 4-Hydroxyproline metabolism and glyoxylate production: a target for substrate depletion in primary hyperoxaluria?. Kidney Int. 2006, 70:1891-1893.
22. Pearce F.G., Dobson R.C., Weber A., Lane L.A., McCammon M.G., Squire M.A., Perugini M.A., Jameson G.B., Robinson C.V., Gerrard J.A. Mutating the tight-dimer interface of dihydrodipicolinate synthase disrupts the enzyme quaternary structure: toward a monomeric enzyme. Biochemistry 2008, 47:12108-12117.
23. Guo B.B., Devenish S.R., Dobson R.C., Muscroft-Taylor A.C., Gerrard J.A. The C-terminal domain of Escherichia coli dihydrodipicolinate synthase (DHDPS) is essential for maintenance of quaternary structure and efficient catalysis. Biochem. Biophys. Res. Commun. 2009, 380:802-806.
24. Lumb M.J., Birdsey G.M., Danpure C.J. Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro. Biochem. J. 2003, 374:79-87.
25. Santana A., Salido E., Torres A., Shapiro L.J. Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7277-7282.
26. Booth M.P., Conners R., Rumsby G., Brady R.L. Structural basis of substrate specificity in human glyoxylate reductase/hydroxypyruvate reductase. J. Mol. Biol. 2006, 360:178-189.
27. Brooks G.A., Dubouchaud H., Brown M., Sicurello J.P., Butz C.E. Role of mitochondrial lactate dehydrogenase and lactate oxidation in the intracellular lactate shuttle. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:1129-1134.
28. Taylor S.W., Fahy E., Zhang B., Glenn G.M., Warnock D.E., Wiley S., Murphy A.N., Gaucher S.P., Capaldi R.A., Gibson B.W., Ghosh S.S. Characterization of the human heart mitochondrial proteome. Nat. Biotechnol. 2003, 21:281-286.
29. Lange J., Wood K., Knight J., Assimos D., Holmes R.P. Glyoxal formation and its role in endogensous oxalate synthesis. Adv. Urol. 2012, 10.1155/2012/819202.